Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cervical Cancer
Two L1-peptides help detect HPV-associated lesions
July 14th, 2005
According to a report from Colombia, "A persistent high-risk human papillomavirus (HR-HPV) infection causes cervical intraepithelial lesions and cervical carcinoma. "There is evidence that detecting anti-L1 antibodies could be successfully used for discriminating between cervical lesion patients and women having normal cytology." M. Urquiza and colleagues at the Foundation Institute of Immunology of Colombia "found that peptides 18283 ((55)PNNNKILVPKVSGLQYRVFR(74)) and 18294 ((284)LYIKGSGSTANLASSNYFPT(300)) from the L1-surface exposed regions were specifically recognized by antibodies from the cervical lesion patient sera. These peptides were tested...
Source: Women's Health Weekly (2005-07-14)
|
